Businesses
Here's a look at documents from U.S. and international businesses
Featured Stories
Squire Patton Boggs Recognized in Legal 500 EMEA 2026
TYSONS, Virginia, March 28 -- Squire Patton Boggs, a law firm, issued the following news:
* * *
Squire Patton Boggs Recognized in Legal 500 EMEA 2026
In the newly published 2025 edition of Legal 500 Europe, Middle East & Africa, Squire Patton Boggs has been recommended for its expertise across practices and locations.
For dispute resolution and arbitration, Squire Patton Boggs "houses a large team, with strong activity in disputes linked to Latin America, Central Asia, and North Africa, as well as Central Europe." The team "can combine forces with colleagues from the firm's other international
... Show Full Article
TYSONS, Virginia, March 28 -- Squire Patton Boggs, a law firm, issued the following news:
* * *
Squire Patton Boggs Recognized in Legal 500 EMEA 2026
In the newly published 2025 edition of Legal 500 Europe, Middle East & Africa, Squire Patton Boggs has been recommended for its expertise across practices and locations.
For dispute resolution and arbitration, Squire Patton Boggs "houses a large team, with strong activity in disputes linked to Latin America, Central Asia, and North Africa, as well as Central Europe." The team "can combine forces with colleagues from the firm's other internationaloffices (particularly in the US and Dubai), manages a strong investment arbitration caseload, mainly representing states ... in large and sensitive disputes, including several billion-dollar cases. The team also handles commercial arbitration, while its diverse range of work spans various industry sectors, including construction, energy and infrastructure." In litigation work, the firm is also active across numerous industries such as the energy, insurance, corporate, real estate, and financial services sectors, as well as the pharmaceuticals, biotechnology, medical devices, digital health and research sectors. Clients have commented, "The team is truly extraordinary, and the support they provide always adds value."
For transactional work, Squire Patton Boggs offers "outstanding client service" and acts across sectors, "well equipped to handle domestic and cross-border M&A, buyouts, and disposals, as well as investments, divestments, and commercial agreements." The private equity practice frequently receives instructions from sponsors, investment funds, management teams and shareholders related to mid-market leveraged buyouts and related cross-border transactions, with clients describing "a technical and practical team, agile and collaborative, offering clear solutions for complex operations. They stand out for their close customer relationships and modern approach."
The firm also "covers a myriad banking and finance issues spanning acquisition, project, and real estate finance for a broad portfolio of international financial institutions and multinational corporations."
In Brussels, Squire Patton Boggs has "expanded its capabilities in chemical and environmental policy" and has "notable expertise in chemical and environmental regulations, and the practice provides advocacy, regulatory compliance, and litigation services, representing clients before EU courts and regulatory bodies."
Recommended Practices:
Belgium
* Commercial, Corporate and M&A
* Competition - EU and Global
* EU Regulatory - Chemicals
Czech Republic
* Banking, Finance and Capital Markets
* Commercial, Corporate and M&A
* Dispute Resolution
* Employment
* Real Estate and Construction
France
* Dispute Resolution - International Arbitration
* Dispute Resolution - White-Collar Crime - Firm to Watch
* EU, Competition and Distribution - Firm to Watch
* Employment
* Industry Focus - Healthcare and Life Sciences
* Insurance
* Intellectual Property: Patents
* Private Equity - LBO
Germany
* Corporate
* Real Estate
Ireland
* Commercial, Corporate and M&A
Italy
* Commercial, Corporate and M&A
* Industry Focus - Energy
* Tax
Poland
* Banking and Finance
* Dispute Resolution
* Employment
* Energy and Natural Resources
* TMT
Slovakia
* Commercial, Corporate and M&A
* Dispute Resolution
* Employment
* Real Estate and Construction
Spain
* Banking and Finance
* Commercial, Corporate and M&A
* Data Privacy and Data Protection
* Dispute Resolution
* Employment
* Private Equity
* Projects and Energy
* Real Estate and Construction
* Tax
Saudi Arabia
* Commercial, Corporate and M&A
United Arab Emirates
* Commercial, Corporate and M&A
* Construction (including Disputes)
* Dispute Resolution - Arbitration and International Litigation
* Dispute Resolution - Compliance and Investigations
* Employment
Individual recognitions:
Commercial, Corporate and M&A
* Marek Hrubes (Czech Republic)
* Omar Momany (United Arab Emirates)
* Matt Powell (United Arab Emirates)
Data Privacy and Data Protection
* Bartolome Martin (Spain)
Dispute Resolution
* Eva Dragunova (Slovakia)
* Rostislav Pekar (Czech Republic)
* Vladimir Polach (Czech Republic)
* Maria Polakova (Czech Republic)
* Tatiana Prokopova (Slovakia)
* Matej Pustay (Czech Republic)
Dispute Resolution - Compliance and Investigations
* Richard Gibbon (United Arab Emirates)
Dispute Resolution: International Arbitration
* Jose Ricardo Feris (France)
Employment
* Malgorzata Grzelak (Poland)
* Sabina Krajickova (Czech Republic)
* Sarah Lawrence (United Arab Emirates)
* Habib Saeed (United Arab Emirates)
EU Regulatory - Chemicals
* Thomas Delille (Belgium)
* Peter Sellar (Belgium)
Industry Focus - Energy
* Paolo Zamberletti (Italy)
Insurance
* Valerie Ravit (France)
* Carole Sportes (France)
Real Estate and Construction
* Lenka Landro (nee Vagundova) (Slovakia)
* Lenka Nova (Czech Republic)
* Tatiana Prokopova (Slovakia)
* * *
Original text here: https://www.squirepattonboggs.com/news/squire-patton-boggs-recognized-in-legal-500-emea-2026/
[Category: BizLaw/Legal]
McDonald Hopkins' Co-President Jim Stief Joins Crain's Cleveland Law Power Breakfast Panel
CLEVELAND, Ohio, March 28 -- McDonald Hopkins, a law firm, issued the following news on March 27, 2026:
* * *
McDonald Hopkins' Co-President Jim Stief joins Crain's Cleveland Law Power Breakfast panel
James Stief
McDonald Hopkins' Co-President Jim Stief recently joined fellow Cleveland law firm leaders as a panelist at the Crain's Cleveland Law Power Breakfast, hosted by Crain's Cleveland Business at The Union Club.
The March 25 event brought together prominent voices from across the legal industry for a thoughtful discussion on how firms are navigating a rapidly evolving landscape. Topics
... Show Full Article
CLEVELAND, Ohio, March 28 -- McDonald Hopkins, a law firm, issued the following news on March 27, 2026:
* * *
McDonald Hopkins' Co-President Jim Stief joins Crain's Cleveland Law Power Breakfast panel
James Stief
McDonald Hopkins' Co-President Jim Stief recently joined fellow Cleveland law firm leaders as a panelist at the Crain's Cleveland Law Power Breakfast, hosted by Crain's Cleveland Business at The Union Club.
The March 25 event brought together prominent voices from across the legal industry for a thoughtful discussion on how firms are navigating a rapidly evolving landscape. Topicsincluded talent recruitment and retention, the growing role of AI, and shifting client expectations.
The event was moderated by journalist Jeremy Nobile.
Throughout the conversation, panelists shared what gives them optimism about the legal profession, as well as the challenges that require careful navigation. From adapting to new technologies to meeting the evolving needs of clients, the discussion highlighted how firm leadership is positioning their organizations for long-term success.
We're proud to see Jim contributing to these important industry conversations and helping shape the future of the legal profession in Cleveland and beyond.
* * *
James Stief
Member
jstief@mcdonaldhopkins.com
* * *
Original text here: https://www.mcdonaldhopkins.com/insights/news/mcdonald-hopkins-co-president-jim-stief-joins-crains-cleveland-law-power-breakfast-panel
[Category: BizLaw/Legal]
Legal 500 EMEA 2026 Ranks Mayer Brown in 35 Categories and Recognises 21 Lawyers as Leading Individuals
CHICAGO, Illinois, March 28 [Category: BizLaw/Legal] -- Mayer Brown, a law firm, issued the following news:
* * *
The Legal 500 EMEA 2026 ranks Mayer Brown in 35 categories and recognises 21 lawyers as leading individuals
The Legal 500 Europe, Middle East and Africa (EMEA) 2026 guide has ranked Mayer Brown in 35 practice categories.
Of these categories, three are Top-Tier:
* Belgium: Customs, trade, WTO and anti-dumping
* Belgium: EU regulatory: Chemicals
* Germany: Structured finance and securitisation - Derivatives
The guide recognised four Mayer Brown lawyers in the "Hall of Fame". Paulette
... Show Full Article
CHICAGO, Illinois, March 28 [Category: BizLaw/Legal] -- Mayer Brown, a law firm, issued the following news:
* * *
The Legal 500 EMEA 2026 ranks Mayer Brown in 35 categories and recognises 21 lawyers as leading individuals
The Legal 500 Europe, Middle East and Africa (EMEA) 2026 guide has ranked Mayer Brown in 35 practice categories.
Of these categories, three are Top-Tier:
* Belgium: Customs, trade, WTO and anti-dumping
* Belgium: EU regulatory: Chemicals
* Germany: Structured finance and securitisation - Derivatives
The guide recognised four Mayer Brown lawyers in the "Hall of Fame". PauletteVander Schueren was ranked in the Customs, trade, WTO and anti-dumping category, Nathalie Jalabert-Doury was ranked for EU, competition and distribution, Marc Santoni was ranked in Insolvency and Laurent Borey was ranked in Tax.
The guide also listed 15 Mayer Brown lawyers as "Leading Partners" in the following practice areas:
* Belgium: Nikolay Mizulin - Customs, trade, WTO and anti-dumping
* Belgium: Jean-Philippe Montfort - EU regulatory: Chemicals
* France: Patrick Teboul - Banking and finance: transactional work
* France: Dany Khayat - Dispute Resolution: International Arbitration
* France: Alejandro Lopez Ortiz - Dispute Resolution: International Arbitration
* France: Julien Haure - Employment
* France: Olivier Meledo - Project Finance
* France: Olivier Meledo - Energy projects
* France: Alban Dorin - Mining, oil and gas and natural resources
* France: Olivier Aubouin - Private Equity: LBO
* France: Olivier Tordjman - Private Equity: LBO
* France: Benjamin Homo - Private Equity Tax
* France: Elodie Deschamps - Transactional/Corporate Tax
* Germany: Christian Horstkotte - Antitrust
* Germany: Patrick Scholl - Structured Finance and securitisation
* United Arab Emirates: Tom Thraya - Corporate and M&A
A further four Mayer Brown lawyers are recognised as "Next Generation Partners":
* Belgium: Pavlina Chopova-Lepretre - EU Regulatory: Chemicals
* France: Jean-Maxime Blutel - EU, competition and distribution
* United Arab Emirates: Farid Haroun - Commercial, Corporate and M&A
* United Arab Emirates: Priya Shah - Oil, gas and natural resources
In addition, two Mayer Brown lawyers are recognised as "Leading Associates":
* Belgium: Dylan Geraets - Customs, trade, WTO and anti-dumping
* Germany: Inga Rupp - Restructuring and insolvency
Below is a full list of the practice categories in which Mayer Brown is ranked:
* Belgium: Competition: EU and global
* Belgium: Customs, trade, WTO and anti-dumping
* Belgium: EU regulatory: Chemicals
* France: Banking and finance: transactional work
* France: Compliance
* France: Derivatives and structured finance
* France: Dispute resolution: Commercial litigation
* France: Dispute resolution: International arbitration
* France: Employment
* France: EU, competition and distribution
* France: Industry Focus: Energy
* France: Insolvency
* France: M&A: large to mid-market deals (above Euros100m)
* France: Private equity: LBO
* France: Project finance
* France: Real estate
* France: Tax
* Germany: Antitrust
* Germany: Financial services: regulatory
* Germany: Lending and borrowing
* Germany: Real estate finance
* Germany: Debt capital markets
* Germany: Structured finance and securitisation
* Germany: Structured finance and securitisation - Derivatives
* Germany: Corporate
* Germany: M&A: mid-sized deals
* Germany: Patent litigation: solicitors
* Germany: Trade marks
* Germany: PE transactions: mid-sized deals (Euros100m-Euros500m)
* Germany: Real estate
* Germany: Restructuring
* Mozambique: Foreign law firms
* United Arab Emirates: Commercial, corporate and M&A
* United Arab Emirates: Dispute resolution: arbitration and international litigation
* United Arab Emirates: Oil, gas and natural resources
* * *
Original text here: https://www.mayerbrown.com/en/news/2026/03/the-legal-500-emea-2026-ranks-mayer-brown-in-35-categories-and-recognises-21-lawyers-as-leading-individuals
Jeremy Paner Discusses Sanctions Compliance Lessons From Reports of $1.7B in Binance Linked Cryptocurrency Transfers to Iran
NEW YORK, March 28 -- Hughes Hubbard and Reed, a law firm, issued the following news:
* * *
Jeremy Paner Discusses Sanctions Compliance Lessons from Reports of $1.7B in Binance Linked Cryptocurrency Transfers to Iran
What sanctions compliance lessons emerge from reports of Binance linked cryptocurrency transactions involving Iran?
Highlights
* Jeremy Paner examines sanctions compliance risks highlighted by reports of $1.7 billion in Binance linked cryptocurrency transfers to the Iran's Islamic Revolutionary Guard Corps.
* The article outlines how investigators traced the transactions and
... Show Full Article
NEW YORK, March 28 -- Hughes Hubbard and Reed, a law firm, issued the following news:
* * *
Jeremy Paner Discusses Sanctions Compliance Lessons from Reports of $1.7B in Binance Linked Cryptocurrency Transfers to Iran
What sanctions compliance lessons emerge from reports of Binance linked cryptocurrency transactions involving Iran?
Highlights
* Jeremy Paner examines sanctions compliance risks highlighted by reports of $1.7 billion in Binance linked cryptocurrency transfers to the Iran's Islamic Revolutionary Guard Corps.
* The article outlines how investigators traced the transactions anduncovered red flags tied to a third party vendor.
* Paner underscores that shared addresses are an indicator of potential sanctions evasion schemes.
*
Jeremy Paner discussed sanctions compliance lessons with The New York Times after investigators found roughly $1.7 billion in cryptocurrency flowing to Iranian entities from Binance-linked accounts, despite numerous sanctions compliance red flags.
The article breaks down how Binance records show transactions worth the equivalent of hundreds of millions of dollars are connected to an address of a BIS Entity List sanctioned company.
Those transactions led investigators to Blessed Trust, a little-known payment processing firm that handled back-office tasks for Binance while using the exchange to move $1.2 billion that ultimately went to sanctioned Iranian entities, according to company records and other documents reviewed by The New York Times.
According to the Times, it took Binance about a year to end its relationship with Blessed Trust, despite several warning signs appearing in public records, raising questions about whether the company has done enough to stop money laundering and sanctions evasion.
Paner specifically discussed Binance's failure to react to the shared address of a BIS Entity List sanctioned company.
"Common addresses are and have been a standard sanctions evasion tool going back a generation," Paner said.
* * *
Original text here: https://www.hugheshubbard.com/news/jeremy-paner-discusses-sanctions-compliance-lessons-from-reports-of-1-7b-in-binance-linked-cryptocurrency-transfers-to-iran
[Category: BizLaw/Legal]
Jeremy Paner Discusses Continued US Restrictions on Cuba as Country Moves to Open Its Economy
NEW YORK, March 28 -- Hughes Hubbard and Reed, a law firm, issued the following news:
* * *
Jeremy Paner Discusses Continued US Restrictions on Cuba as Country Moves to Open its Economy
New Cuban investment policy highlights limits of U.S. law and ongoing sanctions.
Highlights
* Cuba announces that nationals living abroad may invest in and own private businesses, however the U.S. trade embargo continues to restrict investment by Cuban Americans.
* Former OFAC official Paner says Cuba's move is aimed at signaling Washington, not attracting U.S. investors.
* Congressional action or a declared
... Show Full Article
NEW YORK, March 28 -- Hughes Hubbard and Reed, a law firm, issued the following news:
* * *
Jeremy Paner Discusses Continued US Restrictions on Cuba as Country Moves to Open its Economy
New Cuban investment policy highlights limits of U.S. law and ongoing sanctions.
Highlights
* Cuba announces that nationals living abroad may invest in and own private businesses, however the U.S. trade embargo continues to restrict investment by Cuban Americans.
* Former OFAC official Paner says Cuba's move is aimed at signaling Washington, not attracting U.S. investors.
* Congressional action or a declaredtransitional government would be required to ease sanctions.
*
Jeremy Paner discussed Cuba's move to open its economy to Cuban nationals living abroad - and the U.S. restrictions that remain in place - in an interview with South Florida NPR station WLRN.
The Cuban government announced this week that Cuban nationals living abroad will be permitted to invest in and own private businesses on the island, marking a significant policy shift. However, for much of the Cuban diaspora - particularly in Florida - the longstanding U.S. trade embargo creates substantial legal barriers to participation.
"U.S. law is nowhere near authorizing those investments. I mean, it's just not even - it's not a close call," Paner said.
Paner added that Cuba's announcement was in reality meant to signal to the U.S. government that it is willing to play ball and negotiate a solution to the countries' ongoing geopolitical standoff. But in order to get anywhere meaningful on the economic front, those negotiations could require U.S. actions as well.
"It's kabuki theater," said Paner. "They're signaling to the U.S. government. They're not signaling to potential investors in Miami because they know - I know that they know - that those investments are not allowed under U.S. law."
The U.S. restrictions on doing business in Cuba pertain to any currency transactions that involve the U.S. dollar, leaving room for investment by those using other currencies. This includes the Euro, which is being used by a growing population of expatriate Cubans in Spain.
"If Cubans living in Spain want to invest in Cuba, then there is no [Office of Foreign Assets Control] jurisdictional hook, then they could do that," said Paner. "OFAC can kind of play in the margins of the existing dollar prohibitions, but they cannot get rid of the prohibitions."
A potential way to get around the U.S. side of the economic sanctions would be for President Trump to declare that a "transitional" government is in place on the island to ease the restrictions.
"The word 'transition government' is an important thing. It's not that the government is suddenly pro-democracy or whatever. It's a new government," said Paner. "If the [Cuban] government puts in the grand nephew as the new leader, or someone that has a familiar relation to Castro, that's the same government. It's not a transitional government."
Another way around the restrictions would be for Congress to repeal the U.S. Embargo on Cuba to open business relations, as the sanctions on Cuba uniquely cannot be quickly changed at the discretion of the President.
"The executive branch is very limited as to what it can do," said Paner. "Cuba remains the strictest comprehensive sanctions program that the United States has ever had. You'd think, you know, North Korea, Iran. No. It's still Cuba."
* * *
Original text here: https://www.hugheshubbard.com/news/jeremy-paner-discusses-continued-us-restrictions-on-cuba-as-country-moves-to-open-its-economy
[Category: BizLaw/Legal]
GSK: Bepirovirsen Accepted for Review by the European Medicines Agency as a Potential First-In-Class Treatment for Chronic Hepatitis B
LONDON, England, March 28 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on March 27, 2026:
* * *
Bepirovirsen accepted for review by the European Medicines Agency as a potential first-in-class treatment for chronic hepatitis B
- Submission supported by statistically significant and clinically meaningful functional cure rates in pivotal PhIII B-Well trials.
- Nearly 3.2 million people in Europe live with chronic hepatitis B (CHB), a leading cause of liver cancer./1
*
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency
... Show Full Article
LONDON, England, March 28 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on March 27, 2026:
* * *
Bepirovirsen accepted for review by the European Medicines Agency as a potential first-in-class treatment for chronic hepatitis B
- Submission supported by statistically significant and clinically meaningful functional cure rates in pivotal PhIII B-Well trials.
- Nearly 3.2 million people in Europe live with chronic hepatitis B (CHB), a leading cause of liver cancer./1
*
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency(EMA) has accepted for review the marketing authorisation application (MAA) for the use of bepirovirsen, an investigational antisense oligonucleotide (ASO), in the treatment of adults with chronic hepatitis B (CHB).
Chronic hepatitis B remains a public health concern in Europe, with an estimated 3.2 million people living with CHB./1 The current standard of care - nucleos(t)ide analogues - often requires lifelong therapy and the functional cure rates remain low, typically only 1%./2 Functional cure occurs when the hepatitis B virus DNA and viral protein - hepatitis B surface antigen (HBsAg) - are undetectable in the blood for at least 24 weeks after stopping all treatment, indicative of the disease being controlled by the immune system without medication. It is estimated that ~56% of liver cancer cases globally are caused by CHB./3
The regulatory submission to EMA is based on positive results from the B-Well 1 and B-Well 2 Phase III trials. Both trials met their primary endpoint, and bepirovirsen demonstrated a statistically significant and clinically meaningful functional cure rate. Functional cure rates were significantly higher with bepirovirsen plus standard of care compared with standard of care alone. Results were statistically significant across all ranked endpoints, including in patients with baseline surface antigen (HBsAg) <=1000 IU/ml where an even greater effect was demonstrated. The trials demonstrated an acceptable safety and tolerability profile consistent with what was reported in other studies. These data will be presented at a congress and submitted for scientific peer-reviewed publication in 2026.
* * *
About chronic hepatitis B
Hepatitis B is a viral infection that can cause both acute and chronic liver disease. Chronic hepatitis B occurs when the immune system is unable to clear the virus, resulting in long-lasting infection that affects more than 250 million people worldwide. The disease causes approximately 1.1 million deaths each year globally/4, including an estimated 15,000 in Europe.1 Many patients require lifelong antiviral therapy for viral suppression, making functional cure a critical goal in disease management. The European Association for the Study of the Liver (EASL) guidelines identify functional cure as the ultimate goal of treatment./5
* * *
About bepirovirsen
Bepirovirsen is a triple action investigational antisense oligonucleotide (ASO), designed to recognise and orchestrate the destruction of the genetic components (i.e. mRNA and pregenomic RNA) of the hepatitis B virus that can lead to chronic disease, potentially allowing a person's immune system to regain control. Bepirovirsen inhibits the replication of the viral genome in the body, suppresses the level of hepatitis B surface antigen (HBsAg) in the blood, and stimulates the immune system to increase the chances of a durable and sustained response.
* * *
About B-Well Clinical trial programmes
B-Well 1 and B-Well 2 trials are global multi-centre, randomised, double-blind, placebo-controlled trials conducted in 29 countries. They assessed the efficacy, safety, pharmacokinetic profile, and the durability of functional cure in nucleos(t)ide analogue (NA)-treated participants with CHB and baseline surface antigen (HBsAg) 3000 IU/ml. The primary endpoint assessed the proportion of participants achieving functional cure in patients with baseline surface antigen (HBsAg) 3000 IU/ml. A key ranked secondary endpoint evaluated functional cure in participants with baseline HBsAg 1000 IU/ml. Functional cure is defined as hepatitis B surface antigen (HBsAg) loss and undetectable HBV DNA for at least 24 weeks after a finite course of treatment.
Bepirovirsen is also being evaluated as a potential backbone therapy for future sequential treatment strategies aimed at expanding functional cure to broader patient populations.
GSK licensed bepirovirsen from Ionis Pharmaceuticals and collaborated with them on its development. Bepirovirsen is currently not approved anywhere in the world.
* * *
Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the "Risk Factors" section in GSK's Annual Report on Form 20-F for 2025.
* * *
References
1./ European Centre for Disease Prevention and Control. World Hepatitis Day 2025: Hepatitis burden remains high across the EU/EEA. 28 July 2025. Available at : https://www.ecdc.europa.eu/en/news-events/world-hepatitis-day-2025 (last accessed February 2026).
2./ Slaets, L. et al. "Systematic review with meta-analysis: hepatitis B surface antigen decline and seroclearance in chronic hepatitis B patients on nucleos(t)ide analogues or pegylated interferon therapy" in GastroHep 2, 106-116 (2020)
3./ Maucort-Boulch, D., de Martel, C., Franceschi, S. and Plummer, M. (2018), Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. Int. J. Cancer, 142: 2471-2477. Available at: https://doi.org/10.1002/ijc.31280 (last accessed March 2026)
4./ WHO Global Hepatitis Report 2024. Available at https://www.who.int/publications/i/item/9789240091672 (last accessed March 2026)
5./ EASL Guidelines available at https://easl.eu/publication/easl-guidelines-management-of-hepatitis-b/ (last accessed March 2026)
* * *
Original text here: https://www.gsk.com/en-gb/media/press-releases/bepirovirsen-accepted-for-review-by-the-european-medicines-agency-as-a-potential-first-in-class-treatment-for-chronic-hepatitis-b/
[Category: BizPharmaceuticals]
Crowell Recognized Among Top Firms in Legal 500 EMEA 2026
WASHINGTON, March 28 -- Crowell and Moring, a law firm, issued the following news:
* * *
Crowell Recognized Among Top Firms in Legal 500 EMEA 2026
Brussels: The Legal 500 Europe, Middle East & Africa (EMEA) 2026 edition has recognized 13 practice areas and nine lawyers in Crowell & Moring's Brussels office.
Legal 500 evaluates the legal market, gathering feedback from over 300,000 in-house counsel worldwide and conducting in-depth interviews with leading lawyers. The publication seeks to "highlight the practice area teams who are providing the most cutting edge and innovative advice to corporate
... Show Full Article
WASHINGTON, March 28 -- Crowell and Moring, a law firm, issued the following news:
* * *
Crowell Recognized Among Top Firms in Legal 500 EMEA 2026
Brussels: The Legal 500 Europe, Middle East & Africa (EMEA) 2026 edition has recognized 13 practice areas and nine lawyers in Crowell & Moring's Brussels office.
Legal 500 evaluates the legal market, gathering feedback from over 300,000 in-house counsel worldwide and conducting in-depth interviews with leading lawyers. The publication seeks to "highlight the practice area teams who are providing the most cutting edge and innovative advice to corporatecounsel."
The following Crowell practice groups and lawyers were ranked:
Banking, Finance, and Capital Markets
Banking, Finance, and Capital Markets - Qatar
Competition
Competition: EU & Global - Belgium
Competition: Belgian Law - Belgium/*
Partner Thomas De Meese - Competition: Belgian Law - Belgium - Leading Partner
Commercial, Corporate, and M&A
Commercial, Corporate, and M&A - Belgium
Customs, Trade, WTO And Anti-Dumping
Customs, Trade, WTO And Anti-Dumping - Belgium
Dispute Resolution
Dispute Resolution - Belgium/*
Partner Werner Eyskens - Dispute Resolution - Belgium - Leading Partner
Counsel Evelien Van Espen - Dispute Resolution - Belgium - Leading Associate
Employment
Employment - Belgium
Partner Evelien Jamaels - Employment - Belgium - Next Generation Partner
EU Regulatory: Privacy & Data Protection
EU Regulatory: Privacy & Data Protection - Belgium
EU Regulatory: Pharma, Medical Devices & Biotech
EU Regulatory: Pharma, Medical Devices & Biotech - Belgium/*
Partner Kristof Roox - EU Regulatory: Pharma, Medical Devices & Biotech - Belgium - Leading Partner
Partner Jurgen Figys - EU Regulatory: Pharma, Medical Devices & Biotech - Belgium - Next Generation Partner
Industry Focus: Healthcare & Life Sciences
Industry Focus: Healthcare & Life Sciences - Belgium/*
Partner Kristof Roox - Industry Focus: Healthcare & Life Sciences - Belgium - Hall of Fame
Partner Jurgen Figys - Industry Focus: Healthcare & Life Sciences - Belgium - Next Generation Partner
Industry Focus: IT & Telecoms
Industry Focus: IT & Telecoms - Belgium/*
Partner Thomas De Meese - Industry Focus: IT & Telecoms - Belgium - Hall of Fame
Partner Sari Depreeuw - Industry Focus: IT & Telecoms - Belgium - Leading Partner
Industry Focus: Media & Entertainment
Industry Focus: Media & Entertainment - Belgium/*
Partner Thomas De Meese - Industry Focus: Media & Entertainment - Belgium - Hall of Fame
Partner Sari Depreeuw - Industry Focus: IT & Telecoms - Belgium - Leading Partner
Partner Jan-Diederik Lindemans - Industry Focus: Media & Entertainment - Belgium - Leading Partner
Partner Edward Taelman - Industry Focus: Media & Entertainment - Belgium - Next Generation Partner
Industry Focus: Food
Industry Focus: Food - Belgium/*
Intellectual Property
Intellectual Property - Belgium/*
Partner Sari Depreeuw - Leading Partner
Partner Jan-Diederik Lindemans - Intellectual Property - Belgium - Leading Partner
Partner Kristof Roox - Intellectual Property - Belgium - Hall of Fame
Partner Edward Taelman - Intellectual Property - Belgium - Next Generation Partner
* * *
*/ Indicates first or second tier ranking
* * *
About Crowell & Moring LLP
Crowell & Moring is an international law firm with operations in the United States, Europe, and MENA. Drawing on significant government, business, industry, and legal experience, the firm helps clients capitalize on opportunities and provides creative solutions to complex regulatory and policy, litigation, transactional, and intellectual property issues. The firm is consistently recognized for its commitment to pro bono service, as well as its comprehensive programs and initiatives to advance the professional and personal development of all members of the Crowell community.
* * *
Original text here: https://www.crowell.com/en/insights/firm-news/crowell-recognized-among-top-firms-in-legal-500-emea-2026
[Category: BizLaw/Legal]
